SEC Form 4 · accession 0001689375-26-000043
Entrada Therapeutics, Inc. · TRDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gina Chapman
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 5:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001689375
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.97 | Jun 10, 2026 | A | 19,000 | A | — | Jun 10, 2036 | Common Stock | 19,000 | 19,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 10, 2026 or (ii) the Issuer's next annual meeting of stockholders.